SPRY4 and cancer: Increasing studies had demonstrated that SPRY4-IT1 was up-regulated in various cancers, such as the cervical cancer (Cao et al. 2016), the bladder cancer (Liu et al. 2017), and the esophageal cancer (Cui et al. 2016), and it was identified to promote tumor growth and metastasis.